Company / Total Debt
Amgen Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$54.6B
FY2025
5-year range
$33.3B / $64.6B
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
#3 of 86
Health Care
What the data says
Among 86 Health Care companies, Amgen is in the bottom 3% for total debt. Total Debt has fluctuated over the past 10 years, ranging from $29.9B in FY2019 to $64.6B in FY2023.
Based on SEC 10-K filings.
$54.6B in FY2025 with a 5-year CAGR of +10.6%. Ranks 3rd among 86 companies in Health Care.
Improved from $64.6B to $54.6B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 86This company $54.6B Sector average $6.0B
▼
+817.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, total debt decreased 9.1% year-over-year.
- Ranks #3 out of 86 companies in the Health Care sector.
- Peak total debt was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.6B | -9.1% |
| FY2024 | $60.1B | -7.0% |
| FY2023 | $64.6B | +65.9% |
| FY2022 | $38.9B | +16.9% |
| FY2021 | $33.3B | +1.0% |
| FY2020 | $33.0B | +10.3% |
| FY2019 | $29.9B | -11.9% |
| FY2018 | $33.9B | -4.0% |
| FY2017 | $35.3B | +2.2% |
| FY2016 | $34.6B | +10.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026